Rob O'Dell

Rob O'Dell serves as VP R&D, CTO at Amylyx Pharmaceuticals. Amylyx Pharmaceuticals operates in the pharmaceuticals sector with approximately 170.0 employees. The company is headquartered in Santa Rosa, California. Amylyx Pharmaceuticals generates annual revenue of 380800000.0.

Industry & Role Insights

• • MessageCEO tracks 1,288 executives in the pharmaceuticals sector.
• • 13,743 executive contacts are available in California.
• • Our database includes 201,469 c suite-level executives.

NetSuite CSC Corporate Domains Amazon AWS Media Temple SSL OneTrust Adobe Marketing Cloud reCAPTCHA Google Tag Manager Google Maps (Non Paid Users) Varnish Mobile Friendly Google Font API MouseFlow Google Analytics Vimeo MailChimp Greenhouse.io New Relic Bootstrap Framework Google Maps Nginx Typekit Remote AI

als neurodegenerative diseases amyotrophic lateral sclerosis wolfram syndrome postbariatric hypoglycemia progressive supranuclear palsy biotechnology: pharmaceutical preparations health care pharmaceutical manufacturing clinical trials fda breakthrough therapy patient support innovative treatments scientific research community engagement collaboration drug development amx0035 avexitide clinical trial design healthcare providers advocacy organizations neuroinflammation patient-centric glucagon-like peptide-1 receptor antagonist sodium phenylbutyrate taurursodiol phase 2 trials research partnerships biotech healthcare technology clinical research drug efficacy safety profiles technology in healthcare patient resources neurodegeneration treatment collaborative research rare diseases investigational drugs therapeutic development research funding patient care community resources quality of life healthcare access medical research research data cell death neurological health investor relations medical information bio-pharmaceuticals clinical-stage pharmaceutical innovative therapies unmet medical needs investigational therapies amx0114 research & development patient-centered care healthcare professionals caregivers neurological disorders partnerships collaborations biopharmaceutical commercialization global expansion scientific excellence transformative treatments patient advocacy metabolic disorders breakthrough therapy orphan drug designation drug discovery healthcare innovation patient empowerment rigorous science strategic restructuring financial transparency investor engagement health wellness & fitness pharmaceuticals medical hospital & health care

YM

Yathendra Madineni Chief Executive Officer at 4C Pharma Solutions

RB

Ronan Brown Chief Operating Officer at 4G Clinical

HK

Hitoshi Kamiya Chief Executive Officer at A2 Healthcare Corporation

LJ

Lars Jensen CEO at A-apoteket

TL

Tien Lee CEO at Aardvark Therapeutics, Inc.

How can I contact Rob O'Dell?

Rob O'Dell's verified email address is available on MessageCEO. They currently work at Amylyx Pharmaceuticals. Pro subscribers can access direct email addresses for over 200,000 executives.

What company does Rob O'Dell lead?

Rob O'Dell is VP R&D, CTO at Amylyx Pharmaceuticals, a company in the pharmaceuticals sector with 170.0 employees. The company is based in Santa Rosa, California.

What industry is Rob O'Dell in?

Rob O'Dell works in the pharmaceuticals industry as VP R&D, CTO at Amylyx Pharmaceuticals. MessageCEO provides verified contact information for executives across all major industries.

Is Rob O'Dell's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Rob O'Dell's profile is kept up-to-date with the latest available information.

Last updated: April 9, 2026